Table 1. Clinical characteristics of adult LVAD recipients who bridged to heart transplantation.

Demographics	Data (n=39)
Male (%)	31 (79.5)
Female (%)	8 (20.5)
FPHC (%)	10 (25.6)
Male (%)	10 (100.0)
Age at LVAD placement (years)	53.9±14.5
Etiology of cardiomyopathy (%)
Ischemic	23 (59.0)
Non-ischemic	14 (35.9)
Mixed or unknown	2 (5.1)
Type of LVAD (%)
HMII	32 (82.1)
HW	4 (10.3)
VentrAssist	3 (7.7)

LVAD, left ventricular assist device; FPHC, false-positive hepatitis C antibody; HMII, HeartMate II; HW, HeartWare.